Point-of-care testing of coagulation in patients treated with edoxaban

Edoxaban, alongside other direct oral anticoagulants (DOAC), is increasingly used for prevention of thromboembolism, including stroke. Despite DOAC therapy, however, annual stroke rate in patients with atrial fibrillation remains 1–2%. Rapid exclusion of relevant anticoagulation is necessary to guid...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thromb Thrombolysis
Asıl Yazarlar: Härtig, Florian, Birschmann, Ingvild, Peter, Andreas, Hörber, Sebastian, Ebner, Matthias, Sonnleitner, Matthias, Spencer, Charlotte, Bombach, Paula, Stefanou, Maria-Ioanna, Kuhn, Joachim, Mengel, Annerose, Ziemann, Ulf, Poli, Sven
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer US 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515947/
https://ncbi.nlm.nih.gov/pubmed/32436010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02143-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller